KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Deferred Taxes: 2010-2025

Historic Deferred Taxes for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to -$10.2 million.

  • Emergent BioSolutions' Deferred Taxes fell 239.73% to -$10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.9 million, marking a year-over-year increase of 42.72%. This contributed to the annual value of -$5.5 million for FY2024, which is 38.20% up from last year.
  • Per Emergent BioSolutions' latest filing, its Deferred Taxes stood at -$10.2 million for Q3 2025, which was up 26.62% from -$13.9 million recorded in Q2 2025.
  • Over the past 5 years, Emergent BioSolutions' Deferred Taxes peaked at $45.4 million during Q4 2021, and registered a low of -$54.1 million during Q4 2022.
  • Over the past 3 years, Emergent BioSolutions' median Deferred Taxes value was -$1.7 million (recorded in 2023), while the average stood at -$1.8 million.
  • Per our database at Business Quant, Emergent BioSolutions' Deferred Taxes soared by 4,027.27% in 2021 and then plummeted by 6,850.00% in 2025.
  • Quarterly analysis of 5 years shows Emergent BioSolutions' Deferred Taxes stood at $45.4 million in 2021, then plummeted by 219.16% to -$54.1 million in 2022, then spiked by 90.39% to -$5.2 million in 2023, then surged by 92.31% to -$400,000 in 2024, then plummeted by 239.73% to -$10.2 million in 2025.
  • Its last three reported values are -$10.2 million in Q3 2025, -$13.9 million for Q2 2025, and $18.6 million during Q1 2025.